Edwards Lifesciences ROE - Return on Equity 2010-2024 | EW
- Edwards Lifesciences average return on equity for 2023 was 22.98, a 10.51% increase from 2022.
- Edwards Lifesciences average return on equity for 2022 was 25.68, a 6.04% decline from 2021.
- Edwards Lifesciences average return on equity for 2021 was 27.33, a 24.97% decline from 2020.
Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.